Novartis unit Sandoz set to start trading after completing spinoff
October 04, 2023 at 01:51 AM EDT
Novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which will begin trading on the SIX Swiss Exchange on Wednesday.
